Bassi, Pierfrancesco
 Distribuzione geografica
Continente #
EU - Europa 17.999
NA - Nord America 7.386
AS - Asia 2.301
AF - Africa 63
SA - Sud America 49
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 12
Totale 27.829
Nazione #
IT - Italia 10.870
US - Stati Uniti d'America 7.265
DE - Germania 2.494
SE - Svezia 1.441
CN - Cina 972
UA - Ucraina 736
SG - Singapore 619
FR - Francia 604
IE - Irlanda 344
GB - Regno Unito 325
PL - Polonia 285
IN - India 246
NL - Olanda 223
ID - Indonesia 215
RU - Federazione Russa 172
FI - Finlandia 168
CA - Canada 88
BE - Belgio 85
CH - Svizzera 73
TR - Turchia 70
JP - Giappone 66
ES - Italia 41
CI - Costa d'Avorio 34
BR - Brasile 22
RO - Romania 22
IR - Iran 21
HK - Hong Kong 19
MA - Marocco 17
KR - Corea 15
AT - Austria 14
CZ - Repubblica Ceca 13
BZ - Belize 12
EU - Europa 12
VN - Vietnam 12
LT - Lituania 11
AR - Argentina 10
AL - Albania 8
AU - Australia 8
CO - Colombia 8
GR - Grecia 8
PT - Portogallo 8
HU - Ungheria 7
MX - Messico 7
MY - Malesia 7
TW - Taiwan 7
DO - Repubblica Dominicana 6
PA - Panama 6
RS - Serbia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
PH - Filippine 5
SM - San Marino 5
TH - Thailandia 5
BG - Bulgaria 4
EC - Ecuador 4
MD - Moldavia 4
HR - Croazia 3
IL - Israele 3
IS - Islanda 3
LU - Lussemburgo 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
A1 - Anonimo 2
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
CL - Cile 2
CV - Capo Verde 2
DK - Danimarca 2
EG - Egitto 2
IQ - Iraq 2
LK - Sri Lanka 2
MT - Malta 2
NO - Norvegia 2
PE - Perù 2
UG - Uganda 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CM - Camerun 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
HN - Honduras 1
IM - Isola di Man 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LI - Liechtenstein 1
MC - Monaco 1
ME - Montenegro 1
OM - Oman 1
PG - Papua Nuova Guinea 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 27.829
Città #
Chandler 1.612
Milan 1.123
Rome 955
Ashburn 626
Singapore 500
Jacksonville 424
Dublin 332
San Mateo 331
Ann Arbor 311
Naples 277
Wilmington 243
Nanjing 241
Jakarta 208
Florence 197
Turin 188
Warsaw 182
Dearborn 152
Bologna 151
Houston 147
Woodbridge 144
Los Angeles 143
Palermo 142
New York 135
Bremen 129
Munich 128
Nanchang 124
Nürnberg 122
Lawrence 114
Bari 113
Fairfield 106
Genoa 104
Boston 102
Moscow 95
Catania 92
Cattolica 90
Beijing 88
Marseille 88
Verona 88
Redwood City 86
Kraków 83
Princeton 78
Brussels 71
Seattle 71
Chicago 58
Lancaster 55
Mountain View 55
Brescia 53
Padova 52
Falls Church 51
Ottawa 50
Venice 46
Kunming 45
Redmond 42
Izmir 40
Boardman 37
Helsinki 36
Tianjin 36
Cambridge 35
Abidjan 34
Parma 34
University Park 34
Hebei 33
Messina 33
Perugia 33
Livorno 32
Cagliari 31
Norwalk 31
San Jose 31
Jiaxing 30
Salerno 30
Bergamo 29
Shenyang 29
Hangzhou 28
Kadoma 28
Reggio Emilia 28
Changsha 27
Pescara 27
Toronto 26
Trieste 26
Augusta 25
Taranto 25
London 22
Modena 22
Lucca 21
Paris 21
Shanghai 20
Amsterdam 19
Leawood 19
Saint Petersburg 19
Caserta 18
Enterprise 18
Novara 18
Changchun 17
Guangzhou 17
Monza 17
Rimini 17
Simi Valley 17
Andover 16
Kiselëv 16
Macerata 16
Totale 12.461
Nome #
Le disfunzioni sessuali maschili in pazienti con insufficienza renale cronica end stage ed in pazienti sottoposti a trapianto renale 7.995
Iniezione transuretrale intracervicale di tossina botulinica tipo A nel trattamento della dissinergia del collo vescicale refrattaria a terapia medica 1.007
Iniezione intracervicale di OnabotulinotossinaA per il trattamento dell'ostruzione primitiva del collo vescicale refrattaria alla terapia medica. Una nuova opzione terapeutica 754
Ruolo della risonanza magnetica funzionale (DCE-MRI, DWI-MRI)in pazienti sottoposti a saturation biopsy per persistente sospetto di carcinoma prostatico nonostante un primo set bioptico negativo: risultati preliminari su esperienza monocentrica 733
Il ruolo della chemioimmunoterapia endovescicale nella neoplasia della vescica non muscolo invasiva “ non responder” 439
MALAT1 and HOTAIR long non-coding RNAs play opposite role in estrogen-mediated transcriptional regulation in prostate cancer cells 335
High intensity focused ultrasound (HIFU) in prostate cancer: today’s outcomes and tomorrow’s perspectives 302
La tecnologia robotica nel contesto urologico italiano: analisi economica costo-efficacia 300
Studio trasversale sui sintomi e sulle complicanze del basso apparato urinario e sul loro impatto sulla qualità  della vita connessa alla salute (HRQL) in una coorte di pazienti con sclerosi multipla (MS) utilizzando questionari standardizzati 255
Efficacia di un programma supervisionato perioperatorio di fisioterapia del pavimento pelvico per il miglioramento del recupero della continenza dopo prostatectomia radicale: trial randomizzato controllato 254
High-intensity focused ultrasound in prostate cancer: Today's outcomes and tomorrow's perspectives 253
Pros-IT CNR: an Italian prostate cancer monitoring project 220
Efficacy of a supervised low-intensity regimen of perioperative pelvic floor muscle training in reducing postprostatectomy urinary incontinence: A randomized controlled trial 192
(99m)Tc-MAG3 diuretic renography in diagnosis of obstructive nephropathy in adults: a comparison between F-15 and a new procedure F+10(sp) in seated position 178
H19-Dependent Transcriptional Regulation of β3 and β4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer. 178
E-CADHERIN AND IL-6 SERUM LEVELS IN PATIENTS AFFECTED BY PROSTATE CANCER BEFORE AND AFTER PROSTATECTOMY 177
Le infezioni delle vie urinarie 172
Do testis germinal tumours express PTTG (Pituitary Transforminf Tumour Gene) 169
SEXUAL DYSFUNCTIONS IN PATIENTS AFFECTED BY MULTIPLE SCLEROSIS: EVALUATION IN A CONTEMPORARY COHORT FROM A REFERRAL CENTER 165
Soluble E-cadherin and IL-6 serum levels in patients affected by prostate cancer before and after prostatectomy 152
Sexual outcomes after organ potency-sparing surgery and glans reconstruction in patients with penile carcinoma 144
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary results 144
Evidenze microbiologiche in un singolo centro urologico 138
Urological complications following inguinal hernioplasty 134
OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes 133
Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinence 129
The occult urothelial cancer 129
Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial 126
Complications of Extracorporeal Shock Wave Lithotripsy for Urinary Stones: To Know and to Manage Them–A Review 126
[Urinary peptides and calcium oxalate nephrolithiasis, a combined approach: MALDI-TOF mass spectrometry and MicroBCA Protein Assay] 126
Chirurgia robotica per tutti 124
Robot technology in the Italian Health-CARE system: cost-efficacy economic analysis 123
Le complicanze nella chirurgia urologica 123
[Overactive bladder syndrome: the social and economic perspective] 122
Male infertility: non-surgical therapy 121
Paraneoplastic Dermatomyositis Associated With Panurothelial Transitional Cell Carcinoma: A Case Report and Literature Review 121
Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex 120
Endourethral migration of a Hem-o-Lok Clip after robot-assisted laparoscopic radical prostatectomy 120
Hifu as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 119
Imaging in prostate cancer diagnosis: present role and future perspectives 117
(99m)Tc-Mag3 Diuretic Renography In Assessment Of Obstructive Uropathy. The New Test F+10sp: A Step Ahead In The Differential Diagnosis 117
Extracorporeal shockwave lithotripsy in pediatrics 116
Human factors in surgery: from Three Mile Island to the operating room 114
Advanced bladder cancer: New agents and new approaches. A review 114
IMAGING IN BLADDER CANCER: PRESENT ROLE AND FUTURE PERPECTIVES.Totaro A, Pinto F, Brescia A, Racioppi M, Cappa E, D'Agostino D, Volpe A, Sacco E, Palermo G, Valentini AL, Bassi PF. 114
KV7 channels in the human detrusor: channel modulator effects and gene and protein expression 114
Bladder and prostate metastasis from small cell lung cancer: a rare entity 114
Metabolic reprogramming by malat1 depletion in prostate cancer 114
[Foreign bodies in urinary bladder: a clinical case] 113
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study 113
L' era del PCA3: risultati preliminari di uno studio pragmatico monocentrico 112
Brachytherapy in men with prostate cancer: update on indications and outcomes 112
Hot topics in urological health economics. A mini review 111
Meccanismo d'azione del bioconiugato idrosolubile paclitaxel-acido ialuronico su linee cellulari umane di tumore della vescica 111
Positive surgical margins in nephron sparing surgery for renal cell carcinoma 111
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 108
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia treated with intraprostatica onabotulinumtoxinA: 3 month results of a prospective single-armed cohort study 108
Imaging in prostate cancer staging: present role e future perspectives 108
Antibiotic prophylaxis in urology 108
Size of Bladder Cancers: Correlation among Different Types of Measurement 105
Behavioural profile and human adaptation of survivors after radical cystectomy and ileal conduit 105
NBI: results review 105
Postoperative Quality of Life in Patients with Ileal Neobladder at Short-, Intermediate- and Long-Term Follow-Up 105
HER-2 immunohistochemical expression as prognostic marker in high-grade T1 bladder cancer (T1G3) 104
Clinical, pathological and molecular prognostic factors in prostate cancer decision-making process 104
Germ Cell Neoplasia in situ (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs) 103
Imaging of renal cell carcinoma: state of the art and recent advances 102
Treatment of bladder neck dissynergia with transurethral injection of OnabotulinumtoxinA: objective and patient-reported results 102
The Clinical Use of Statistical Permutation Test Methodology: A Tool for Identifying Predictive Variables of Outcome 100
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 100
ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk "bCG failure" non muscle invasive bladder cancer: 3 years follow-up outcomes 100
Advanced bladder cancer: New agents and new approaches. A review 99
Imaging in prostate cancer staging: present role and future perspectives 98
Neutrophil gelatinase-associated lipocalin (NGAL) value changes before and after shock wave lithotripsy 98
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 96
Male sexual dysfunction in patients with chronic end-stage renal insufficiency and in renal transplant recipients 96
Bradeion (SEPT4) as a Urinary Marker of Transitional Cell Bladder Cancer: A Real-Time Polymerase Chain Reaction Study of Gene Expression 96
Inhibition of prostate efferent neurotransmission by amikacin 95
Development of a questionnaire specifically for patients with Ileal Orthotopic Neobladder (IONB) 95
Surgery for male urinary incontinence: where are we now and what is in the pipeline? 95
Is microsurgical technique really necessary in inguinal or sub-inguinal surgical treatment of varicocele? 93
Bladder pain syndrome associated with highest impact on sexual function among women with lower urinary tract symptoms 92
Current status of robotic urologic surgery in Italy 92
Imaging in Prostate Cancer Diagnosis: Present Role and Future Perspectives. 91
[Innovative treatments of non muscle invasive bladder cancer] 90
High intensity focused ultrasound as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 90
Test F+10 SP: un nuovo metodo angioscintigrafico per la diagnosi dell'uropatia ostruttiva 89
Thermochemotherapy for non-muscle-invasive bladder cancer: is there a chance to avoid early cystectomy? 89
Therapeutic strategies in penile cancer: state of the art 89
Value of Current Chemotherapy and Surgery in Advanced and Metastatic Bladder Cancer 88
Second-line intravesical therapy. What is the present role of device-assisted therapy? 88
Mitomycin C: new strategies to improve efficacy of a well-known therapy 88
The occult urothelial cancer 88
Circumcision: history, religion and law 87
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging-Hystopatology correlations 87
Is extracorporeal shock wave lithotripsy in pediatrics a safe procedure? 86
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 86
Local relapse of prostate cancer after primary definitive treatment: the management 86
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 84
Imaging of renal cell carcinoma: state of the art and recent advances 84
Totale 22.771
Categoria #
all - tutte 83.076
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.076


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.462 0 0 0 0 0 175 196 128 303 119 325 216
2020/20212.007 84 198 114 200 266 135 195 76 221 108 305 105
2021/20222.258 214 147 77 180 185 112 79 294 138 158 302 372
2022/20235.943 680 630 414 770 338 637 267 472 634 280 477 344
2023/20246.857 383 803 431 547 474 594 526 625 449 612 640 773
2024/20254.447 639 752 877 713 951 515 0 0 0 0 0 0
Totale 28.109